Skip to main content

Table 4 Results of the multivariate analysis of MRSA vs. MSSA endocarditis

From: Clinical and prognostic differences between methicillin-resistant and methicillin-susceptible Staphylococcus aureus infective endocarditis

 

OR

95% CI

COPD

3.19

1.4–7.23

Early prosthetic IE

2.13

0.69–3.98

Nosocomial or healthcare-related IE

1.64

0.69–3.99

Cardiomyopathy

2.22

0.84–5.91

Congenital disease

0

0

Arterial hypertension

1.16

0.54–2.49

Hemodialysis

0

0

Charlson’s index

0.92

0.776–1.095

Invasive procedure and/or focus of infection

2.95

1.14–7.65

IVDA

1.18

0.21–6.66

Osler’s node

0.73

0.163–3.24

Janeway lesion

0.737

0.137–3.96

Duke vascular or embolic phenomena

0.19

0.716–5.493

Delay in hospital care

3.94

1.64–9.468

Echocardiography with perivalvular lesion

0.395

0.15–1.03

Adequate antibiotic therapy

0.532

0.214–1.321

  1. COPD Chronic Obstructive Pulmonary Disease; IVDA intravenous drug addiction